2 studies found for:    9203648 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Anti-HIV Immune Serum Globulin (Human);   Drug: Globulin, Immune;   Drug: Zidovudine
2 Completed Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)
Conditions: Acquired Immunodeficiency Syndrome;   Disease Transmission, Vertical;   HIV Infections
Intervention: Drug: immunoglobulins

Indicates status has not been verified in more than two years